MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species
暂无分享，去创建一个
T. Sellers | V. Gonzalez | R. León | M. Martín | C. Rodríguez-Antolín | Patrycja Michalska | O. Pernía | S. Sacristan | Álvaro García-Guede | Julia Jiménez | B. Reid | J. de Castro | I. Esteban‐Rodríguez | Rocío Rosas | I. I. de Cáceres | Olga Vera‐Puente | Ana Salgado-Figueroa | V. González | M. E. Martín | Olga Pernía | Elena M. Martin | C. Rodríguez‐Antolín